The great challenge of managing recipients of hematopoietic stem cell transplantation combined with COVID-19
- 1 March 2021
- journal article
- letter
- Published by Springer Science and Business Media LLC in Bone Marrow Transplantation
- Vol. 56 (3), 696-700
- https://doi.org/10.1038/s41409-020-01035-6
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- COVID-19 pandemic and impact on hematopoietic stem cell transplantationBone Marrow Transplantation, 2020
- COVID-19 in posttransplant patients—report of 2 casesAmerican Journal of Transplantation, 2020
- SARS-CoV-2 Transmission in Patients With Cancer at a Tertiary Care Hospital in Wuhan, ChinaJAMA Oncology, 2020
- Covid-19 and Kidney TransplantationThe New England Journal of Medicine, 2020
- COVID-19 in solid organ transplant recipients: Initial report from the US epicenterAmerican Journal of Transplantation, 2020
- Earliest cases of coronavirus disease 2019 (COVID-19) identified in solid organ transplant recipients in the United StatesAmerican Journal of Transplantation, 2020
- Hospital-based use of thromboprophylaxis in patients with COVID-19The Lancet, 2020
- American Society for Transplantation and Cellular Therapy Pharmacy Special Interest Group Position Statement on Pharmacy Practice Management and Clinical Management for COVID-19 in Hematopoietic Cell Transplantation and Cellular Therapy Patients in the United StatesTransplantation and Cellular Therapy, 2020
- Facing COVID-19 in the hematopoietic cell transplant setting: A new challenge for transplantation physiciansBlood Cells, Molecules, and Diseases, 2020
- Outcomes of allogeneic haematopoietic stem cell transplantation from HLA-matched and alternative donors: a European Society for Blood and Marrow Transplantation registry retrospective analysisThe Lancet Haematology, 2019